These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 11674859)

  • 1. The possible association of in vivo leukocyte-platelet heterophilic aggregate formation and the development of diabetic angiopathy.
    Kaplar M; Kappelmayer J; Veszpremi A; Szabo K; Udvardy M
    Platelets; 2001 Nov; 12(7):419-22. PubMed ID: 11674859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Platelet-monocyte aggregate formation in patients with coronary heart disease and disorders of carbohydrate metabolism].
    Telejko B; Zak J; Bachórzewska-Gajewska H; Nowak K; Nikołajuk A; Dobrzycki S; Kinalska I
    Pol Arch Med Wewn; 2004 Sep; 112(3):1067-73. PubMed ID: 15727088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced leukocyte-platelet cross-talk in Type 1 diabetes mellitus: relationship to microangiopathy.
    Hu H; Li N; Yngen M; Ostenson CG; Wallén NH; Hjemdahl P
    J Thromb Haemost; 2004 Jan; 2(1):58-64. PubMed ID: 14717967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated beta-thromboglobulin levels and circulating platelet aggregates in diabetic microangiopathy.
    Preston FE; Ward JD; Marcola BH; Porter NR; Timperley WR; O'Malley BC
    Lancet; 1978 Feb; 1(8058):238-40. PubMed ID: 74664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship between glycemic control and platelet activity in type 2 diabetes mellitus.
    Demirtunc R; Duman D; Basar M; Bilgi M; Teomete M; Garip T
    J Diabetes Complications; 2009; 23(2):89-94. PubMed ID: 18358749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet adhesion and aggregate formation in type I diabetes under flow conditions.
    Nievelstein PF; Sixma JJ; Ottenhof-Rovers M; Wynne HJ; De Groot PG; Banga JD
    Diabetes; 1991 Nov; 40(11):1410-7. PubMed ID: 1936602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet in progression of atherosclerosis: a potential target in diabetic patients.
    Koyama H; Nishizawa Y
    Curr Diabetes Rev; 2005 May; 1(2):159-65. PubMed ID: 18220591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating platelet-leukocyte aggregates: a marker of microvascular injury in diabetic patients.
    Elalamy I; Chakroun T; Gerotziafas GT; Petropoulou A; Robert F; Karroum A; Elgrably F; Samama MM; Hatmi M
    Thromb Res; 2008; 121(6):843-8. PubMed ID: 17825880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of calpain in diabetes-associated platelet hyperactivation.
    Randriamboavonjy V; Fleming I
    Adv Pharmacol; 2010; 59():235-57. PubMed ID: 20933204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-risk type-2 diabetes mellitus patients, without prior ischemic events, have normal blood platelet functionality profiles: a cross-sectional study.
    Shlomai G; Haran-Appel T; Sella T; Grossman Y; Hauschner H; Rosenberg N; Grossman E
    Cardiovasc Diabetol; 2015 Jun; 14():80. PubMed ID: 26068309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Shear-induced platelet adhesion and aggregation on subendothelium are increased in diabetic patients.
    Knobler H; Savion N; Shenkman B; Kotev-Emeth S; Varon D
    Thromb Res; 1998 May; 90(4):181-90. PubMed ID: 9692617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leukocyte-platelet aggregates in acute and subacute ischemic stroke.
    Marquardt L; Anders C; Buggle F; Palm F; Hellstern P; Grau AJ
    Cerebrovasc Dis; 2009; 28(3):276-82. PubMed ID: 19609079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clopidogrel but not aspirin reduces P-selectin expression and formation of platelet-leukocyte aggregates in patients with atherosclerotic vascular disease.
    Klinkhardt U; Bauersachs R; Adams J; Graff J; Lindhoff-Last E; Harder S
    Clin Pharmacol Ther; 2003 Mar; 73(3):232-41. PubMed ID: 12621388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of vitamin E administration on platelet function in diabetes mellitus.
    Kunisaki M; Umeda F; Inoguchi T; Watanabe J; Nawata H
    Diabetes Res; 1990 May; 14(1):37-42. PubMed ID: 2134664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of prasugrel on ADP-stimulated markers of platelet activation in patients with sickle cell disease.
    Jakubowski JA; Zhou C; Winters KJ; Lachno DR; Howard J; Payne CD; Mant T; Jurcevic S; Frelinger AL
    Platelets; 2015; 26(5):474-9. PubMed ID: 25140584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased leukocyte-platelet adhesion in chronic myeloproliferative disorders with high platelet counts.
    Kaplar M; Kappelmayer J; Kiss A; Szabo K; Udvardy M
    Platelets; 2000 May; 11(3):183-4. PubMed ID: 10938896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelets and diabetic vascular disease.
    Paton RC; Passa P
    Diabete Metab; 1983 Dec; 9(4):306-12. PubMed ID: 6230270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The formation of platelet-leukocyte aggregates varies during the menstrual cycle.
    Rosin C; Brunner M; Lehr S; Quehenberger P; Panzer S
    Platelets; 2006 Feb; 17(1):61-6. PubMed ID: 16308189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 'Spontaneous' platelet aggregation in whole blood in diabetic patients with and without microvascular disease.
    Hendra TJ; Yudkin JS
    Diabet Med; 1992 Apr; 9(3):247-51. PubMed ID: 1576806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do platelet apoptosis, activation, aggregation, lipid peroxidation and platelet-leukocyte aggregate formation occur simultaneously in hyperlipidemia?
    Sener A; Ozsavci D; Oba R; Demirel GY; Uras F; Yardimci KT
    Clin Biochem; 2005 Dec; 38(12):1081-7. PubMed ID: 16253220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.